title: Therapeutic targeting of epidermal growth factor receptor with monoclonal antibodies.
authors.affiliation: Falck Division of Medical Oncology, Department of Oncology and Hematology, Niguarda Ca' Granda Hospital, Milan, Italy.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Siena
authors.forename: Salvatore
authors.initials: S
authors.lastname: Artale
authors.forename: Angelo
authors.initials: A
authors.lastname: Vanzulli
authors.forename: Giovanna
authors.initials: G
authors.lastname: Marrapese
authors.forename: Liana
authors.initials: L
authors.lastname: Bevilacqua
authors.forename: Simona
authors.initials: S
authors.lastname: Secondino
authors.forename: Orsola
authors.initials: O
authors.lastname: Sironi
authors.forename: Roberta
authors.initials: R
authors.lastname: Schiavo
authors.forename: Mauro
authors.initials: M
authors.lastname: Moroni
authors.forename: Paolo
authors.initials: P
authors.lastname: Pedrazzoli
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002289:Carcinoma, Non-Small-Cell Lung / Q000276:immunology / Q000628:therapy*; D000068818:Cetuximab; D002986:Clinical Trials as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000276:immunology; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D066246:ErbB Receptors; D000068818:Cetuximab